<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Wyeth (Industry News &amp; Blogs)</title><link>http://www.zibb.com/all/theme/cq/Wyeth</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/Wyeth" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Wed, 18 Nov 2009 16:25:18 GMT</pubDate><lastBuildDate>Wed, 18 Nov 2009 16:25:18 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Wyeth (Industry News &amp; Blogs)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/Wyeth</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>New Book Takes Wyeth (now Pfizer) to Task for Opposition to Bio-I...
      </title><link>http://www.prlog.org/10418595-new-book-takes-wyeth-now-pfizer-to-task-for-opposition-to-bioidentical-hormone-replacement.html</link><description>New Book Takes Wyeth (now Pfizer) to Task for Opposition to Bio-Identical Hormone Replacement. Lane Lenard PhD. and Dr. Jonathan V. Wright’s new book, Stay Young &amp; Sexy with Bio-Identical Hormone Replacement, slams Wyeth and the FDA for hypocrisy regarding stance on Premarin® and Provera®.</description><guid>http://www.prlog.org/10418595-new-book-takes-wyeth-now-pfizer-to-task-for-opposition-to-bioidentical-hormone-replacement.html</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Wed, 18 Nov 2009 16:25:18 GMT</pubDate><source url="http://www.prlog.org" /></item><item><title>Pfizer-Wyeth Merger Rolls Forward; Meetings Casualties Still Unce...
      </title><link>http://meetingsnet.com/medicalmeetings/news/pfizer_wyeth_merger_meetings_1116/</link><description>Pfizer completed its $67 billion acquisition of one-time-competitor Wyeth Pharmaceuticals on October 15, just one in a string of recent mergers and acquisitions in the pharmaceutical industry. (Think Merck s November 3 merger with Schering-Plough and Genentech s March 26 deal with Roche.) According</description><guid>http://meetingsnet.com/medicalmeetings/news/pfizer_wyeth_merger_meetings_1116/</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Tue, 17 Nov 2009 01:40:00 GMT</pubDate><source url="http://meetingsnet.com" /></item><item><title>Progenics: Are the Prospects That Bad?</title><link>http://seekingalpha.com/article/173680-progenics-are-the-prospects-that-bad?source=feed</link><description>David Greene submits:Progenics (PGNX) has been dumped by biotech investors since Oct. 14 when the company announced that Wyeth (&lt;a</description><guid>http://seekingalpha.com/article/173680-progenics-are-the-prospects-that-bad?source=feed</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 16 Nov 2009 22:50:55 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Pfizer Completes Acquisition Of Wyeth</title><link>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=10695</link><description>NEW YORK(BUSINESS WIRE)Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE) announced today that Pfizer has completed its acquisition of Wyeth following the receipt of regulatory approval from all government authorities required by the merger agreement and appro</description><guid>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=10695</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 16 Nov 2009 01:00:00 GMT</pubDate><source url="http://www.pharmiweb.com" /></item><item><title>Pfizer Slashes R and D</title><link>http://pubs.acs.org/cen/news/87/i46/8746notw1.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+cen_latestnews+%28Chemical+%26+Engineering+News%3A+Latest+News%29</link><description>Pfizer Slashes R&amp;D. Pharmaceuticals: company to close six research sites and consolidate others as part of integration with Wyeth</description><guid>http://pubs.acs.org/cen/news/87/i46/8746notw1.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+cen_latestnews+%28Chemical+%26+Engineering+News%3A+Latest+News%29</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Fri, 13 Nov 2009 15:50:00 GMT</pubDate><source url="http://pubs.acs.org" /></item><item><title>Research and Markets: This Report Provides In-Depth Company profi...
      </title><link>http://www.zibb.com/article/5667987/Research+and+Markets+This+Report+Provides+In+Depth+Company+profiles+for+Wyeth+as+ranked+in+the+Fortune+Global+list</link><description>Research and Markets (http://www.researchandmarkets.com/research/36b054/wyeth_2009_fortune) has announced the addition of the "Wyeth 2009 Fortune Global 500 Snapshot Company Profile" company profile to their offering. This report provides in-depth company profiles for Wyeth as ranked in</description><guid>http://www.zibb.com/article/5667987/Research+and+Markets+This+Report+Provides+In+Depth+Company+profiles+for+Wyeth+as+ranked+in+the+Fortune+Global+list</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Fri, 13 Nov 2009 10:18:24 GMT</pubDate><source url="http://www.zibb.com" /></item><item><title>Pfizer absorbing Wyeth at top speed</title><link>http://uk.news.yahoo.com/22/20091111/thl-uk-summit-pfizer-8004a53.html</link><description>Pfizer Inc Chief Executive Officer Jeffrey Kindler said the drugmaker is integrating its Wyeth purchase far faster than previous big acquisitions, and it will no longer be overly</description><guid>http://uk.news.yahoo.com/22/20091111/thl-uk-summit-pfizer-8004a53.html</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Wed, 11 Nov 2009 19:21:00 GMT</pubDate><source url="http://uk.news.yahoo.com" /></item><item><title>Pfizer absorbing Wyeth at top speed</title><link>http://uk.reuters.com/article/idUKTRE5AA3W420091111?feedType=RSS&amp;feedName=businessNews</link><description>NEW YORK (Reuters) - Pfizer Inc  Chief Executive Officer Jeffrey Kindler said the drugmaker is integrating its Wyeth purchase far faster than previous big acquisitions, and it will no longer</description><guid>http://uk.reuters.com/article/idUKTRE5AA3W420091111?feedType=RSS&amp;feedName=businessNews</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Wed, 11 Nov 2009 19:21:06 GMT</pubDate><source url="http://uk.reuters.com" /></item><item><title>Hormone Therapy Victims Win Important Appeal</title><link>http://www.prweb.com/releases/hormone-therapy/hrt-lawsuit/prweb3188274.htm</link><description>PR: On November 2, 2009, the United States Court of Appeals for the Eighth Circuit issued its long-awaited decision in Scroggin v. Wyeth (Case No. 08-2555). The decision gives the green light for federal trials on Wyeth’s and Pfizer’s hormone therapy drugs. In affirming judgment on a jury ve</description><guid>http://www.prweb.com/releases/hormone-therapy/hrt-lawsuit/prweb3188274.htm</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Wed, 11 Nov 2009 13:23:44 GMT</pubDate><source url="http://www.prweb.com" /></item><item><title>Pfizer closes six research sites, cuts 2,000 jobs after buying Wy...
      </title><link>http://www.buffalonews.com/businesstoday/localbusiness/story/856250.html</link><description>TRENTON, N. J.Less than a month after buying Wyeth, drug giant Pfizer Inc. has mapped out a new structure for its research and development operations. The plan, announced Monday, will bring the closure of six of the two companies 20 research facilities, reorganize and consolidate</description><guid>http://www.buffalonews.com/businesstoday/localbusiness/story/856250.html</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Tue, 10 Nov 2009 12:02:18 GMT</pubDate><source url="http://www.buffalonews.com" /></item><item><title>Pfizer to consolidate global R&amp;D</title><link>http://www.drugstorenews.com/story.aspx?id=121913</link><description>With Wyeth under its fold, Pfizer plans to focus research and development on five main centers, mostly in the United States, the drug maker announced Monday.</description><guid>http://www.drugstorenews.com/story.aspx?id=121913</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Tue, 10 Nov 2009 10:25:00 GMT</pubDate><source url="http://www.drugstorenews.com" /></item><item><title>Status of Pfizer and Wyeth research facilities</title><link>http://sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/11/09/financial/f152359S69.DTL&amp;feed=rss.business</link><description>Pfizer Inc., which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites will operate as one. Following is a list of the sites:</description><guid>http://sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/11/09/financial/f152359S69.DTL&amp;feed=rss.business</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 09 Nov 2009 23:24:37 GMT</pubDate><source url="http://sfgate.com" /></item><item><title>Status of Pfizer and Wyeth research facilities</title><link>http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/11/09/financial/f152359S69.DTL&amp;feed=rss.business</link><description>Pfizer Inc., which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites will operate as one. Following is a list of the sites: Former Wyeth sites staying open/Types...</description><guid>http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/11/09/financial/f152359S69.DTL&amp;feed=rss.business</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 09 Nov 2009 23:24:37 GMT</pubDate><source url="http://www.sfgate.com" /></item><item><title>Status of Pfizer and Wyeth research facilities (AP)</title><link>http://finance.yahoo.com/news/Status-of-Pfizer-and-Wyeth-apf-3649406147.html?x=0&amp;.v=1</link><description>Pfizer Inc., which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites</description><guid>http://finance.yahoo.com/news/Status-of-Pfizer-and-Wyeth-apf-3649406147.html?x=0&amp;.v=1</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 09 Nov 2009 23:23:59 GMT</pubDate><source url="http://finance.yahoo.com" /></item><item><title>Pfizer cutting R&amp;D at Research Triangle Park, Sanford (at bizjour...
      </title><link>http://triangle.bizjournals.com/triangle/stories/2009/11/09/daily18.html?ana=yfcpc</link><description>New York-based Pfizer (NYSE: PFE) will cease research-and-development activities in Research Triangle Park and Sanford as part of a major restructuring announced Monday, less than three weeks after the pharmaceutical giant officially brought Wyeth into the fold.</description><guid>http://triangle.bizjournals.com/triangle/stories/2009/11/09/daily18.html?ana=yfcpc</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 09 Nov 2009 22:05:24 GMT</pubDate><source url="http://triangle.bizjournals.com" /></item><item><title>Pfizer Slashes Research, Staff after Wyeth Deal</title><link>http://www.industryweek.com/articles/pfizer_slashes_research_staff_after_wyeth_deal_20375.aspx</link><description>R&amp;D will be conducted at five main sites and nine specialized units around the world, compared with 20 R&amp;D sites.</description><guid>http://www.industryweek.com/articles/pfizer_slashes_research_staff_after_wyeth_deal_20375.aspx</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 09 Nov 2009 21:04:05 GMT</pubDate><source url="http://www.industryweek.com" /></item><item><title>Pfizer trimming research plants, cutting jobs of researchers</title><link>http://www.post-gazette.com/pg/09313/1012080-115.stm?cmpid=news.xml</link><description>TRENTON, N.J. -- Less than a month after buying Wyeth, drug giant Pfizer Inc. has mapped out a new structure for its research and development operations.</description><guid>http://www.post-gazette.com/pg/09313/1012080-115.stm?cmpid=news.xml</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 09 Nov 2009 20:07:00 GMT</pubDate><source url="http://www.post-gazette.com" /></item><item><title>Pfizer trimming research plants after buying Wyeth - The Associat...
      </title><link>http://www.google.com/hostednews/ap/article/ALeqM5hGPlRhvoSj-1LPf5weXCV09kjGDgD9BS6T800</link><description>TRENTON, N.J. — Less than a month after buying Wyeth, drug giant Pfizer Inc. has mapped out a new structure for its research and development operations.</description><guid>http://www.google.com/hostednews/ap/article/ALeqM5hGPlRhvoSj-1LPf5weXCV09kjGDgD9BS6T800</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 09 Nov 2009 19:44:06 GMT</pubDate><source url="http://www.google.com" /></item><item><title>Pfizer trimming research plants after buying Wyeth</title><link>http://www.rdmag.com/News/FeedsAP/2009/11/life-sciences-pfizer-trimming-research-plants-after-buying-wyeth/</link><description>The world's biggest drugmaker said Monday it is closing six of its 20 research facilities, reorganizing and consolidating others, and cutting the jobs of roughly 15 percent of its scientists and support staff. The moves are part of Pfizer Inc.</description><guid>http://www.rdmag.com/News/FeedsAP/2009/11/life-sciences-pfizer-trimming-research-plants-after-buying-wyeth/</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 09 Nov 2009 17:26:03 GMT</pubDate><source url="http://www.rdmag.com" /></item><item><title>Pfizer Cuts Research Facilities After Buying Wyeth</title><link>http://www.npr.org/templates/story/story.php?storyId=120243001&amp;ft=1&amp;f=1001</link><description>Less than a month after buying Wyeth, drug giant Pfizer Inc. has mapped out a new structure for its research and development operations. The plan, announced Monday, will bring the closure of six of their 20 research facilities, reorganize and consolidate others, and cut the jobs of roughly 15</description><guid>http://www.npr.org/templates/story/story.php?storyId=120243001&amp;ft=1&amp;f=1001</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 09 Nov 2009 17:10:00 GMT</pubDate><source url="http://www.npr.org" /></item><item><title>8th Circuit Affirms Arkansas Court Ruling in Products Liability C...
      </title><link>http://www.insurancejournal.com/news/southcentral/2009/11/05/105127.htm</link><description>The U.S. Court of Appeals for the 8th Circuit has upheld Arkansas district court decisions in a products liability case against pharmaceutical companies that are the makers of hormone therapy ...</description><guid>http://www.insurancejournal.com/news/southcentral/2009/11/05/105127.htm</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Thu, 05 Nov 2009 17:58:45 GMT</pubDate><source url="http://www.insurancejournal.com" /></item><item><title>The M&amp;A Trend Continues: An Analysis of the Key Mergers and Acqui...
      </title><link>http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&amp;docid=184146357</link><description>The biggest mergers and acquisitions witnessed so far in 2008 have been the Prizer-Wyeth acquisition for $68 billion, Roche-Genentech $46.8 billion, Merck-Schering Plough $41B and Gilead Sciences-CV Therapeutics $1.4B. This accounted for a total of $157 billion dollars.</description><guid>http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&amp;docid=184146357</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Wed, 04 Nov 2009 00:00:00 GMT</pubDate><source url="http://www.frost.com" /></item><item><title>New damages trial for Wyeth in Ark. hormones case</title><link>http://www.dailyreportonline.com/Editorial/News/singleEdit.asp?individual_SQL=11/3/2009@36509&amp;rssFeed=free</link><description>LITTLE ROCK, Ark. (AP) — Wyeth Pharmaceuticals will get a new trial to determine if the drugmaker should pay punitive damages to a woman who got breast cancer after taking hormone replacement therapy, a federal appeals court ruled Monday.</description><guid>http://www.dailyreportonline.com/Editorial/News/singleEdit.asp?individual_SQL=11/3/2009@36509&amp;rssFeed=free</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Tue, 03 Nov 2009 17:14:00 GMT</pubDate><source url="http://www.dailyreportonline.com" /></item><item><title>Wyeth to Face New Trial on Punitive Damages in Hormone Replacemen...
      </title><link>http://www.law.com/jsp/article.jsp?id=1202435136351&amp;rss=newswire</link><description>Incisive Media's Law.com is the Web's leading legal news and information network for attorneys and other legal professionals.</description><guid>http://www.law.com/jsp/article.jsp?id=1202435136351&amp;rss=newswire</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Tue, 03 Nov 2009 07:04:34 GMT</pubDate><source url="http://www.law.com" /></item><item><title>Video: Operational excellence transforms Wyeth</title><link>http://www.reliableplant.com/article.aspx?articleid=20972</link><description> This is acorporate film featuring sound bite interviews with staffers at different Wyeth locations who have been involved in recent Lean Six Sigma efforts.</description><guid>http://www.reliableplant.com/article.aspx?articleid=20972</guid><category domain="http://www.zibb.com">Wyeth</category><pubDate>Mon, 02 Nov 2009 05:00:00 GMT</pubDate><source url="http://www.reliableplant.com" /></item></channel></rss>